Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 1/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.42 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 3/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.38 |
| ▸ | COMT | P21964 | 1/20 | 0.37 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.36 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20637767 | 0.76 | ACHE (0.47) | ENPP1COMTGPR84ACHENPC1 | |
| SCHEMBL26332330 | 0.75 | COMT (0.53) | COMTGPR84ACHEMAPTNPC1 | |
| SCHEMBL27638536 | 0.72 | AKR1C3 (0.55) | AKR1C3AKR1C2ARPDK2PDE3B | |
| SCHEMBL19323000 | 0.72 | AKR1C3 (0.58) | AKR1C3AKR1C2ARPDK2PDE3B | |
| SCHEMBL1047574 | 0.72 | HSD11B1 (0.52) | ENPP1AKR1C3AKR1C2ARTRPA1 | |
| SCHEMBL23966251 | 0.71 | COMT (0.50) | COMTGPR84ACHEMAPTNPC1 | |
| SCHEMBL13995133 | 0.71 | COMT (0.39) | ENPP1COMTGPR84MAPTNPC1 | |
| SCHEMBL28922699 | 0.71 | HSD11B1 (0.50) | ENPP1AKR1C3AKR1C2ARPDK2 | |
| SCHEMBL13658640 | 0.70 | COMT (0.41) | ENPP1COMTGPR84ACHEMAPT | |
| SCHEMBL18948607 | 0.70 | S1PR1 (0.49) | ARPDK2PDE3BPDE3ATRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024115426-A1 | POLYMERS CONTAINING SPIROTRUXENE DERIVATIVES AS THE REPEATING UNITS, AND ELECTROLUMINESCENT DEVICES CONTAINING SAID POLYMERS | MERCK PATENT GMBH (DE) | 2024-06-06 | — | — | WO | disclosed |
| EP-3559078-B1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-10-25 | — | — | EP | disclosed |
| US-20200144505-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2020-05-07 | — | — | US | disclosed |
| US-20190322796-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2019-10-24 | — | — | US | disclosed |
| EP-1831326-B1 | ELECTROLUMINESCENT POLYMERS AND THEIR USE | MERCK PATENT GMBH (DE) | 2017-03-01 | — | — | EP | disclosed |
| US-20100108989-A1 | ELECTROLUMINESCENT POLYMERS AND USE THEREOF | MERCK PATENT GMBH (DE) | 2010-05-06 | — | — | US | disclosed |
| US-20100108989-A1 | ELECTROLUMINESCENT POLYMERS AND USE THEREOF | MERCK PATENT GMBH (DE) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100108989-A1 | ELECTROLUMINESCENT POLYMERS AND USE THEREOF | MAP1LC3C, EPCAM, MAP1LC3A | ENPP1 674/4885AKR1C3 3844/4885AKR1C2 3309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.